Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NLR family pyrin domain-containing 3 protein (NLRP3) is an intracellular sensor protein, predominantly expressed in immune cells such as macrophages, that acts as a central component of the NLRP3 inflammasome. Structurally, NLRP3 contains a pyrin domain (PYD), a central NACHT domain conferring ATPase activity, and a leucine-rich repeat (LRR) domain that mediates autoregulation. Upon detection of a diverse array of danger signals—including microbial motifs, extracellular ATP, uric acid crystals, and various cellular stressors—NLRP3 oligomerizes and triggers assembly of the inflammasome complex with the adapter ASC and caspase-1, leading to activation and secretion of the pro-inflammatory cytokines IL-1β and IL-18 and induction of pyroptosis. Aberrant or constitutive activation of NLRP3, often due to gain-of-function mutations, underlies several autoinflammatory diseases (collectively referred to as cryopyrin-associated periodic syndromes) and is implicated in diverse pathologies including cardiovascular, metabolic, and neurodegenerative disorders. NLRP3 is considered a high-value therapeutic target, with selective inhibitors such as MCC950 and dapansutrile in clinical development for inflammatory and autoimmune conditions.
Inhibition of NLRP3 inflammasome assembly and activation; Inhibition of ATPase activity in the NACHT domain; Disruption of oligomerization and ASC speck formation; Blocking caspase-1 activation and cytokine release
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NLR family pyrin domain-containing 3 protein (NLRP3).